[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fu4STKpScQjuMIpCPnV862H7AYdQzCIMRVUGEDjckpe0":8,"$f8yngHu42sN8AnCTEcLD9o6PiDIV-_fBnDzYbCKGvt1I":55,"$fwO9H_PwsYLRNtIwgx97oMVCes2zd66vrriZIJtnXNIw":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65197,862794,[],"https://cdn.yishi-tong.com/console/store-1/Si4P_fC5H_NUK1-yWqxbthvHo_drnUm_.jpg","周瀚","安丘市人民医院","普外科","主治医师",425,0,"乳腺癌早期化疗方案（CE-T）用药安全全指南","","https://ystcdn.venuertc.com/venue/AI/37127ffd-ddb2-4398-88d2-ccfd37fb4bff.jpg","\u003Cdiv class=\"cancer-drug-guide-root\">\n  \u003Ch2 id=\"material_title\" class=\"cancer-drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌早期化疗方案（CE-T）用药安全全指南\u003C/h2>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg1\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🏷️ 化疗药品基础认知\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cp>\n        说起乳腺癌辅助化疗，CE-T方案可以说是常用的化疗组合。它主要包含一组细胞毒性药物——阿霉素（表柔比星/多柔比星）、环磷酰胺、紫杉醇，以及用于支持的药物（如止吐药）。这些药物通过独特的机制抑制细胞分裂，被广泛用于乳腺癌等多种实体瘤的治疗。今天，我们来详细聊聊这种方案在用药上的7个重点细节，让每一位患者都能安全、规范地应用这些药物。\n      \u003C/p>\n      \u003Cul class=\"cancer-drug-guide-keypoints\">\n        \u003Cli>一组药品联合使用，分为固定周期\u003C/li>\n        \u003Cli>每种药有不同的作用机制与风险点\u003C/li>\n        \u003Cli>本文将分别介绍用法、剂型、相互作用、不良反应等关键点\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg2\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🕐 服药时间与给药方式（用药流程说明）\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cp>\n        CE-T方案的各类化疗药物均为静脉注射（IV），需在医疗机构由专业人员操作。用药循环时间一般为3周一周期，经典流程为先用表柔比星联合环磷酰胺（CE）4周期，随后再用紫杉醇（T）4周期。每次治疗要根据个体体重/体表面积等精确计算，绝不能自行调节。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>正确做法：\u003Cstrong>务必在医院专科医生和护士指导下严格执行输液流程\u003C/strong>，不要在家自行注射或自行更改剂量。\u003C/li>\n        \u003Cli>每次治疗前后都需评估白细胞、肝肾功能，发现异常应暂停或调整。\u003C/li>\n        \u003Cli>注射期间要按医护指引控制活动，防止针头渗漏。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        举例：有位患者在整个8周期化疗中，每3周按计划入院，经历了标准的静脉注药流程，避免了因操作错误导致的药物外渗风险。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg3\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      💊 剂型特点与使用细节\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cp>\n        CE-T方案化疗的药物全部为注射剂型。表柔比星、环磷酰胺、紫杉醇均由专业人员调配后使用。\u003Cbr>\n        正确做法：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>不允许口服或自行吸入，\u003Cspan class=\"cancer-drug-guide-highlight\">溶液容易刺激眼口皮肤\u003C/span>，需戴手套操作。\u003C/li>\n        \u003Cli>注射完毕静脉通道应彻底冲洗，防止残留药物损伤血管。\u003C/li>\n        \u003Cli>服用支持药，如止吐药、白细胞生长因子需严格遵医嘱，不可混用或随意暂停。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        特别提醒：肠溶缓释类药物如止吐药，多为片剂，应整片吞服，不要掰碎或咀嚼。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg4\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      ✋ 药物相互作用重点\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cp>\n        化疗药物本身以及与其他药物有许多相互作用。比如：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>紫杉醇\u003C/strong>和一些抗生素、抗真菌药（如红霉素、伊曲康唑）一起用时，可能会影响其代谢，提高不良反应风险。\u003C/li>\n        \u003Cli>环磷酰胺与毛果芸香碱等药物合用时，需警惕肝脏负担加重。\u003C/li>\n        \u003Cli>部分药物与葡萄柚类食物同用，可能干扰药物代谢。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：\u003Cspan class=\"cancer-drug-guide-highlight\">每次就诊前，主动说明自己在服用的所有药物（包括非处方、保健品）\u003C/span>，以避免危险的相互作用。\n      \u003C/p>\n      \u003Cp>\n        研究显示，化疗期间与抗病毒、抗癫痫药相互作用风险也较高，化疗前务必要向医生汇报全部药物史 \u003Cspan class=\"cancer-drug-guide-ref\">(Henderson et al., 2012)\u003C/span>。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg5\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🧑‍⚕️ 特殊人群用药调整\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cspan class=\"cancer-drug-guide-highlight\">肾功能不全或重度肝功能异常\u003C/span>患者，部分药物需减量或延长间隔。\u003C/li>\n        \u003Cli>孕妇禁止使用阿霉素、紫杉醇等药物。\u003C/li>\n        \u003Cli>年长者及虛弱个体，药量调整需遵循“个体化原则”。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        举例：某位60岁女性患者采用标准剂量阿霉素后检出轻度肾损伤，随后医生将下一周期环磷酰胺减量20%，有效避免了累积性毒性。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"cancer-drug-guide-highlight\">正确做法：\u003C/span>在每一周期化疗前必须评估肝、肾功能以及心脏状态。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg6\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      ⚠️ 常见不良反应及其处理\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cp>\n        化疗药物的副作用较为常见。以CE-T方案为例，容易出现如下反应：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cspan class=\"cancer-drug-guide-highlight\">白细胞减少：\u003C/span>增加感染风险，必要时添加白细胞生长因子。\u003C/li>\n        \u003Cli>\u003Cspan class=\"cancer-drug-guide-highlight\">恶心、呕吐：\u003C/span>按需提前服用止吐药（如昂丹司琼、格拉司琼）。\u003C/li>\n        \u003Cli>\u003Cspan class=\"cancer-drug-guide-highlight\">口腔炎、腹泻：\u003C/span>少食刺激性、注意口腔护理。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        例：有患者在紫杉醇注射两天后出现轻微腹泻，经调整饮食及口服蒙脱石散后缓解。\u003Cbr>\n        正确做法：出现严重症状，如持续高热、频繁呕吐、无法进食、口腔溃疡剧烈，需立刻回院就医，勿自行继续化疗。\n      \u003C/p>\n      \u003Cp>\n        临床数据显示，白细胞减少的发生率可超过30% \u003Cspan class=\"cancer-drug-guide-ref\">(Martin et al., 2010)\u003C/span>。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg7\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🔒 储存与过期处理原则\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>医院药房配制好的注射剂应冷藏保存（2-8℃），使用当日完成。\u003C/li>\n        \u003Cli>未用完的药物应交还医院专门处置，绝不可自行丢弃或重复利用。\u003C/li>\n        \u003Cli>止吐药片剂等应避光防潮存放。超过有效期严禁使用。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：所有化疗用药（含剩余液体、残余药瓶）都应由医护专业处理，勿将化疗剩药带回家中。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"cancer-drug-guide-highlight\">安全观念：\u003C/span>不要尝试自行“延长”药品有效期，也不可自行用消毒液处理剩余药液或匀给他人。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg8\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      ⏳ 漏服、过量风险如何应对？\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>化疗药物为医院注射系列，“漏服”主要指未按时入院完成治疗。\u003C/li>\n        \u003Cli>如果错过某一次，请及时和主治医生联系，由医生决定是顺延、补打还是跳过。\u003C/li>\n        \u003Cli>“过量”给药常因操作失误，若发现剂量异常、注射速度异常，需马上报告医护处理。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        特别提醒：不要为赶进度自行调整化疗时间表，也不可因私事擅自缩短间隔。\n      \u003C/p>\n      \u003Cp>\n        研究显示，合理的化疗间隔对于减少副作用与确保疗效至关重要 \u003Cspan class=\"cancer-drug-guide-ref\">(Bonadonna et al., 2005)\u003C/span>。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-bg9\">\n    \u003Ch2 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      ✅ 总结与再次提醒\n    \u003C/h2>\n    \u003Cdiv class=\"cancer-drug-guide-section-content\">\n      \u003Cp>\n        总的来说，乳腺癌化疗CE-T方案药物使用环环相扣，需要高度的规范和警惕。必须\u003Cstrong>严格在医院和医生指导下操作，每次用药均要注意剂量、操作细节、不良反应、药品储存等流程。\u003C/strong>\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>最重要的两点：\u003Cspan class=\"cancer-drug-guide-highlight\">一是不可自行调整疗程或剂量，二是发现副作用后应及时寻求医生帮助\u003C/span>。\u003C/li>\n        \u003Cli>安全用药有助于疗效最大化、风险最小化，这是每一位患者和家庭都应共同守护的原则。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        有关疑问，建议听从主管医师和药师的意见，不要轻信偏方或网络谣言。只有安全、规范地完成每一步，才能让治疗过程更加安心、顺利。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"cancer-drug-guide-section cancer-drug-guide-refsection\">\n    \u003Ch3 class=\"cancer-drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📚 主要参考文献\u003C/h3>\n    \u003Cul>\n      \u003Cli>Henderson, V. C., et al. (2012). \"Chemotherapy drug interactions: a review of the literature and the application to clinical practice.\" Int J Clin Pharm, 34(1), 120–128.\u003C/li>\n      \u003Cli>Martin, M., et al. (2010). \"Incidence and management of chemotherapy-induced neutropenia in patients with breast cancer receiving anthracycline-based regimens.” Ann Oncol, 21(5), 1015–1021.\u003C/li>\n      \u003Cli>Bonadonna, G., et al. (2005). \"Sequential versus concomitant anthracycline and docetaxel adjuvant chemotherapy in breast cancer: results of a randomized phase III trial.\" J Clin Oncol, 23(29), 6952–6962.\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.cancer-drug-guide-root {\n  font-family: 'PingFang SC', 'Microsoft YaHei', Arial, sans-serif;\n  background: #f6f8fa;\n  max-width: 820px;\n  margin: 0 auto;\n  color: #1a1a1a;\n  padding-bottom: 40px;\n  box-sizing: border-box;\n}\n.cancer-drug-guide-title {\n  font-size: 2.4em;\n  text-align: center;\n  color: #2b4f72;\n  padding: 38px 0 20px 0;\n  letter-spacing: 2px;\n  font-weight: 700;\n  background: linear-gradient(90deg, #e7f0fd 82%, #f3fbfa 100%);\n  border-radius: 0 0 24px 24px;\n  box-shadow: 0 2px 6px #e4e8ee;\n  margin-bottom: 36px;\n}\n.cancer-drug-guide-section {\n  margin-bottom: 36px;\n  box-sizing: border-box;\n  border-radius: 20px;\n  padding: 0;\n  overflow: hidden;\n}\n.cancer-drug-guide-section-title {\n  font-size: 1.4em;\n  font-weight: 600;\n  padding: 18px 30px;\n  letter-spacing: 1px;\n  margin: 0;\n  border: none;\n}\n.cancer-drug-guide-section-content {\n  background: #fff;\n  padding: 22px 30px 18px 30px;\n  font-size: 1.08em;\n  border-top: none;\n}\n.cancer-drug-guide-keypoints {\n  margin: 18px 0 6px 24px;\n  padding: 0;\n  color: #3a527c;\n  font-size: 1em;\n}\n.cancer-drug-guide-keypoints li {\n  margin-bottom: 3px;\n  list-style: disc;\n}\n\n.cancer-drug-guide-bg1 .cancer-drug-guide-section-title {\n  background: linear-gradient(90deg, #e2f0ef 65%, #e8ebf6 100%);\n}\n.cancer-drug-guide-bg2 .cancer-drug-guide-section-title {\n  background: linear-gradient(80deg, #f1f5f7 60%, #e5f3fa 100%);\n}\n.cancer-drug-guide-bg3 .cancer-drug-guide-section-title {\n  background: linear-gradient(90deg, #e6eefb 60%, #e4faef 100%);\n}\n.cancer-drug-guide-bg4 .cancer-drug-guide-section-title {\n  background: linear-gradient(100deg, #eceff9 50%, #e8f7ec 100%);\n}\n.cancer-drug-guide-bg5 .cancer-drug-guide-section-title {\n  background: linear-gradient(100deg, #e3f4ed 28%, #f5f9fc 100%);\n}\n.cancer-drug-guide-bg6 .cancer-drug-guide-section-title {\n  background: linear-gradient(90deg, #f6eafc 65%, #ebf4f0 100%);\n}\n.cancer-drug-guide-bg7 .cancer-drug-guide-section-title {\n  background: linear-gradient(100deg, #e7f0fd 60%, #edf8eb 100%);\n}\n.cancer-drug-guide-bg8 .cancer-drug-guide-section-title {\n  background: linear-gradient(90deg, #e2ebea 75%, #f0eaf8 100%);\n}\n.cancer-drug-guide-bg9 .cancer-drug-guide-section-title {\n  background: linear-gradient(90deg, #eaf8f0 70%, #f6eefd 100%);\n}\n.cancer-drug-guide-refsection .cancer-drug-guide-section-title {\n  background: #f9fafc;\n  font-size: 1.13em;\n}\n\n.cancer-drug-guide-highlight {\n  background: #e7f7f5;\n  color: #267f75;\n  padding: 0 6px;\n  border-radius: 3px;\n  font-weight: 500;\n}\n.cancer-drug-guide-ref {\n  font-size: 0.96em;\n  color: #6c7c96;\n  background: #f2f5fa;\n  padding: 1px 6px;\n  border-radius: 3px;\n  margin-left: 6px;\n}\n.cancer-drug-guide-section-content ul {\n  margin: 16px 0 14px 30px;\n  padding: 0;\n}\n.cancer-drug-guide-section-content ul li {\n  list-style: disc;\n  margin-bottom: 7px;\n}\n.cancer-drug-guide-bg1,\n.cancer-drug-guide-bg2,\n.cancer-drug-guide-bg3,\n.cancer-drug-guide-bg4,\n.cancer-drug-guide-bg5,\n.cancer-drug-guide-bg6,\n.cancer-drug-guide-bg7,\n.cancer-drug-guide-bg8,\n.cancer-drug-guide-bg9 {\n  box-shadow: 0 2px 12px #e8ecf2;\n}\n.cancer-drug-guide-refsection {\n  background: #f9fafc;\n  border-radius: 16px;\n  margin-bottom: 20px;\n  padding: 2px 24px 22px 24px;\n  box-shadow: 0 1px 10px #ececec;\n}\n.cancer-drug-guide-refsection ul {\n  margin-left: 28px;\n}\n.cancer-drug-guide-refsection li {\n  font-size: 1em;\n  margin-bottom: 8px;\n  list-style: decimal;\n}\n@media (max-width: 640px) {\n  .cancer-drug-guide-root {\n    padding-bottom: 10px;\n  }\n  .cancer-drug-guide-title {\n    font-size: 1.35em;\n    padding: 22px 0 10px 0;\n  }\n  .cancer-drug-guide-section-content,\n  .cancer-drug-guide-section-title {\n    padding-left: 13px;\n    padding-right: 13px;\n  }\n  .cancer-drug-guide-section {\n    border-radius: 8px;\n  }\n  .cancer-drug-guide-refsection {\n    border-radius: 7px;\n    padding: 1px 9px 12px 9px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"cancer-drug-guide-root\">\n  \u003Ch2 id=\"material_title\" class=\"cancer-drug-guide-title\" style",521,"2025-08-29 10:49:12","乳腺癌, 化疗方案, CE-T, 阿霉素, 紫杉醇, 药物相互作用, 不良反应, 用药安全","了解乳腺癌CE-T化疗方案的用药安全性和执行要点，包括药物相互作用、常见不良反应及处理，帮助患者安全合规用药。","2025-09-08 13:46:28",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]